PT‑141 (Bremelanotide) 10mg

 69,00

PT-141 (Bremelanotide) 10 mg – Grail Formula Quality.
Independently verified to exceed 99 percent purity.
Validated for identity, structural integrity and stability.
Supplied as a 10 mg lyophilized peptide with full quality verification.
Within Europe this product is supplied including bacteriostatic water; outside the EU only the peptide vial is provided.
For research use only — not for human or veterinary use.

Availability: In stock: ships within 1 day after payment confirmation.

Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided. For research use only – not for human or veterinary use.   Product Overview PT-141 also known as Bremelanotide is a melanocortin-pathway research peptide evaluated in studies focusing on receptor-associated signalling, structure–function modelling and pathway-level biochemical communication. This lyophilized 10 mg preparation supports reproducible in-vitro testing under defined mechanistic research conditions.   Peptide Overview Scientific interest in melanocortin peptides increased markedly during the 1990s as researchers analysed structural patterns and receptor-specific signalling behaviour. From 2000 to 2015 PT-141 became a reference compound in receptor-binding studies examining selective pathway activation, intracellular communication and comparative signalling behaviour. Between 2015 and 2025 the peptide remained an important model sequence for analysing melanocortin-receptor interactions and pathway-modulation dynamics in experimental in-vitro systems.   Historical Background and Scientific Context Melanocortin receptor research evolved rapidly from the late 1980s onward as laboratories identified distinct receptor subtypes and mapped pathway-specific responses. From 2005 to 2025 PT-141 continued to serve as a stable analytical reference for modelling pathway-cascade behaviour, evaluating receptor-interaction patterns and studying biochemical signalling sequences in controlled environments.   Mechanistic Focus in Research
  • Modelling of melanocortin-receptor signalling pathways
  • Structure–function evaluation under controlled in-vitro conditions
  • Comparative analysis of biochemical signalling cascades
  • Receptor-specific interaction modelling
  • Investigation of regulated intracellular communication processes
 

Grail Formula Quality

Every Grail Formula research peptide undergoes independent laboratory testing for purity, identity, structural integrity and microbial safety. All batches are verified for stability, low endotoxin levels and reproducibility to ensure reliable scientific outcomes.

When You Choose Grail Formula…

Researchers receive fully documented peptides with batch-number traceability, sealed-vial integrity and transparent laboratory verification. EU shipments include sterile bacteriostatic water; outside the EU only the peptide vial is supplied.

Used solely for in vitro experiments and cannot be:

  • Used in clinical trials involving humans
  • Administered to humans as part of an experiment or investigation
  • Supplied to another party for human investigational use
  • Independently verified to exceed 99 percent purity
  • Validated for identity, structural integrity and stability
  • High-quality melanocortin-pathway research peptide
  • Consistent analytical behaviour in receptor-modelling studies
  • EU shipments include bacteriostatic water
  • For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.